glp-1 cardiovascular outcomes news today Glucagon-like peptide 1 receptor agonists: benefits and mechanisms of action GLP-1 receptor agonist versus DPP-4

Gmez-Benito M, Granado N, Garca-Sanz P, Michel A, Dumoulin M, Moratalla R

The same is true for some underlying health conditions, such as diabetes

The AWARD-6 utilized a European quality of life five dimensions visual analog scale, which did not demonstrate any statistical differences between the dulaglutide and liraglutide groups [Dungan et al

Their conclusions similarly highlight the advantages of GLP-1RAs for weight and select metabolic/clinical phenotypes but explicitly note that the evidence chain for long-term follow-up, lean PCOS, and reproductive endpoints (ovulation, pregnancy, and live birth) remains weak

This allows your healthcare provider to monitor your progress and adjust your treatment plan as needed